3D Printed Brain Model Market: Current Analysis and Forecast (2022-2028)

3D printed brain model is defined as a personalized brain model based on a human brain scan and creates an exact replica of the human brain for neurosurgical training and preoperative planning. The introduction of 3D printed brain model is widely used in the screening and learning about neurological diseases to enhance the outcome of patients. The global 3D printed brain model market is growing at a tremendous rate owing to an increase in the incidences of neurological disorders and the associated surge in research activities for novel therapy and early diagnosis. The key players are actively investing as a result of the growing technological developments in neurological instruments. For instance, in November 2022, Stratasys Ltd. made a strategic investment in axial3D with the purpose to make patient-specific 3D printing solutions for hospitals and medical device manufacturers more accessible so it becomes a mainstream healthcare solution.

The 3D Printed Brain Model Market is expected to grow at a steady rate of around 16% owing to the rising incidence and prevalence of neurological disorders, rising awareness of neurodegenerative diseases, and growth in the number of traumatic brain injuries. According to World Health Organization (WHO), in September 2021 more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year. Also, in 2019, globally, 50 million people were diagnosed with epilepsy.

Based on technology, the market is segmented into fused deposition modeling, stereolithography, colorjet printing, multijet/polyjet printing, and others. Fused deposition modeling held a dominant share of the market in 2020 This technique can help in the creation of robust, steady, and long-lasting 3D models. Models produced with this technology are simple, suitable for use in offices and offer a variety of material options. It also offers cost-efficiency and is quite stable. Using this technology, a complicated structure of the brain can be produced with no difficulty.

Based on materials, the 3D printed brain model market has been classified into plastics, polymer, and others. The plastic category is expected to grow with a significant CAGR during the forecast period. This is mainly due to the feasibility, biodegradability, and compatibility with a wide range of 3D printing technologies. The efficiency provided by plastic materials, and the availability of numerous sophisticated thermoplastics are the main reasons propelling this segment.

For a better understanding of the market adoption of the 3D printed brain model industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. North America held a significant share of the market in 2020. This is mainly due to the increasing prevalence of neurological diseases and the rising demand for personalised healthcare will support market expansion in the area. Comparatively speaking, the U.S. embraces new technology and innovations rapidly. This is mainly attributed to the rising number of product launches and the increasing healthcare investments in the region. For instance, in September 2021, Siemens NAEOTOM Alpha got FDA approval and is designed to transform the information from X-ray photons that pass through a patient's body, and are received by a detector, into a detailed 3-dimensional image.

Some of the major players operating in the market include: Stratasys Ltd.; CELLINK; CYFUSE BIOMEDICAL K.K.; Rokit Healthcare Inc.; Medprin; 3D Systems, Inc.; Formlabs; Voxeljet AG; Medivisuals Inc.; Allevi, Inc.